Anjonette Colvin, OD
Optometrist · Fort Worth, TXNPI 1114918943
Payments from drug & device makers
Across 44 payments — averaging $94.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optos, Inc.$2K
- Alcon$802
- Coopervision Inc.$307
- Bausch & Lomb, A Division Of Bausch Health US, LLC$170
- Bausch & Lomb Americas Inc.$122
- Biotissue Holdings Inc.$84
- plus $278 from 7 others
What the payments were for
- Speaking & faculty fees$822%
- Food & beverage$1,67940%
- Entertainment$1253%
- Other$2,26855%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optos, Inc. | 4 | $2,393 |
| Alcon | 14 | $802 |
| Coopervision Inc. | 9 | $307 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $170 |
| Bausch & Lomb Americas Inc. | 1 | $122 |
| Biotissue Holdings Inc. | 3 | $84 |
| Notal Vision, Inc. | 1 | $82 |
| Johnson & Johnson Vision Care, Inc. | 1 | $81 |
| Tarsus Pharmaceuticals, Inc. | 2 | $34 |
| AbbVie | 1 | $25 |
| Oyster Point Pharma, Inc. | 1 | $22 |
| Novartis | 1 | $19 |
| Kala Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PANORAMIC OPHTHALMOSCOPE$2,268
- TOTAL30$254
- DAILIES TOTAL1 Multifocal$201
- Precision7$183
- INFUSE MULTIFOCAL$122
- BIOTRUE$107
- ULTRA$107
- BIOTRUE ONE DAY$107
How this compares
$4,154 in reported general payments places this provider in the 85th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 27 | $98 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Fort Worth
- Xinnan WangFort Worth$125K
- Robert ChuFort Worth$59K
- Tiffany HuynhHouston$3.2M
- Bridgitte LeeHouston$3M
- Bryan FrazierTyler$1.4M
- Derek CunninghamAustin$940K
- Wendy ChungKaty$900K
- Phillip BrunsonHouston$766K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$568K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.